Paper34623973
Cross-protective immunity following coronavirus vaccination and coronavirus infection.
Dangi T and 9 others. J Clin Invest, 2021. Cited by 79 papers, by iCite.
Cite this record
ConductScience Library. Cross-protective immunity following coronavirus vaccination and coronavirus infection. Papers, record 34623973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34623973
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Viral | Major topic |
| COVID-19 | Major topic |
| COVID-19 Vaccines | Major topic |
| Animals | |
| CD8-Positive T-Lymphocytes | |
| Cross Reactions | |
| Epitope Mapping | |
| Female | |
| Humans | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL | |
| SARS-CoV-2 | |
| Vaccination |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DP2 DA051912 | NIDA NIH HHS | United States | DP2DA051912 | PubMed and NIH | NIH RePORTER |
| R01 AI150672 | NIAID NIH HHS | United States | R01AI150672 | PubMed and NIH | NIH RePORTER |
| T32 AR007611 | NIAMS NIH HHS | United States | T32AR007611 | PubMed | NIH RePORTER |
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32997649 | Recent endemic coronavirus infection is associated with less-severe COVID-19. | J Clin Invest | 2021 | https://conductscience.org/library/papers/32997649 | PubMed |
| 2 | 33536425 | A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2. | Nat Commun | 2021 | https://conductscience.org/library/papers/33536425 | PubMed |
| 3 | 21538303 | Coronaviruses: propagation, quantification, storage, and construction of recombinant mouse hepatitis virus. | Curr Protoc Microbiol | 2011 | https://conductscience.org/library/papers/21538303 | PubMed |
| 4 | 33762420 | A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses. | J Virol | 2021 | https://conductscience.org/library/papers/33762420 | PubMed |
| 5 | 33835391 | Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates. | Virol Sin | 2021 | https://conductscience.org/library/papers/33835391 | PubMed |
| 6 | 32406916 | NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. | Nucleic Acids Res | 2020 | https://conductscience.org/library/papers/32406916 | PubMed |
| 7 | 32940427 | Interrogating Adaptive Immunity Using LCMV. | Curr Protoc Immunol | 2020 | https://conductscience.org/library/papers/32940427 | PubMed |
| 8 | 33971664 | Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. | Nature | 2021 | https://conductscience.org/library/papers/33971664 | PubMed |
| 9 | 33432212 | Could new COVID variants undermine vaccines? Labs scramble to find out. | Nature | 2021 | https://conductscience.org/library/papers/33432212 | PubMed |
| 10 | 33692201 | Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection. | J Virol | 2021 | https://conductscience.org/library/papers/33692201 | PubMed |
| 11 | 23152535 | Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors. | J Virol | 2013 | https://conductscience.org/library/papers/23152535 | PubMed |
| 12 | 15096611 | Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15096611 | PubMed |
| 13 | 33631096 | Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection. | Cell | 2021 | https://conductscience.org/library/papers/33631096 | PubMed |
| 14 | 15823604 | Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein. | Virology | 2005 | https://conductscience.org/library/papers/15823604 | PubMed |
| 15 | 32820330 | Early type I IFN blockade improves the efficacy of viral vaccines. | J Exp Med | 2020 | https://conductscience.org/library/papers/32820330 | PubMed |
| 16 | 34450033 | Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2. | Cell Rep | 2021 | https://conductscience.org/library/papers/34450033 | PubMed |
| 17 | 33031744 | A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice. | Cell | 2020 | https://conductscience.org/library/papers/33031744 | PubMed |
| 18 | 15708987 | Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. | J Virol | 2005 | https://conductscience.org/library/papers/15708987 | PubMed |
| 19 | 33795870 | Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2. | Nat Med | 2021 | https://conductscience.org/library/papers/33795870 | PubMed |
| 20 | 34192529 | SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. | Cell | 2021 | https://conductscience.org/library/papers/34192529 | PubMed |
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931395 | Epitope Mapping and MHC Restriction of Next-Generation Tuberculosis Vaccine Antigens in Mice. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42931395 | PubMed |
| 41986366 | SARS-CoV-2 vaccination and infection elicit cross-neutralizing responses against clade 3 and 4 sarbecoviruses. | Nat Commun | 2026 | https://conductscience.org/library/papers/41986366 | PubMed |
| 41882251 | Design and immunogenicity evaluation of pan-recombinant vaccines based on the consensus sequence of severe acute respiratory syndrome coronavirus-2 spike protein. | Sci Rep | 2026 | https://conductscience.org/library/papers/41882251 | PubMed |
| 41843571 | Pandemic-driven immune imprinting accelerates evolution of human coronavirus OC43. | PLoS Negl Trop Dis | 2026 | https://conductscience.org/library/papers/41843571 | PubMed |
| 41746093 | Challenges and Prospects in the Development of a Universal SARS-CoV-2 Vaccine. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41746093 | PubMed |
| 41648598 | Polymer-lipid hybrid nanoparticle enhances mRNA delivery and T cell-mediated immunity. | bioRxiv | 2026 | https://conductscience.org/library/papers/41648598 | PubMed |
| 41602055 | Respiratory symptom patterns in healthcare workers in Germany: a prospective study during the SARS-CoV-2 pandemic. | Front Public Health | 2025 | https://conductscience.org/library/papers/41602055 | PubMed |
| 41493091 | Humoral epitope dominance and immune imprinting by SARS-CoV-1 and SARS-CoV-2 vaccines. | Immunol Cell Biol | 2026 | https://conductscience.org/library/papers/41493091 | PubMed |
| 41484970 | Effect of COVID-19 vaccination and SARS-CoV-2 infection status on mortality risk in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study. | Respir Res | 2026 | https://conductscience.org/library/papers/41484970 | PubMed |
| 41295541 | Current Status and Challenges of Vaccine Development for Seasonal Human Coronaviruses. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41295541 | PubMed |
| 41236793 | Innate immune memory: The evolving role of macrophages in therapy. | Elife | 2025 | https://conductscience.org/library/papers/41236793 | PubMed |
| 41212056 | Comparative analysis of adenovirus, mRNA, and protein vaccines reveals context-dependent immunogenicity and efficacy. | JCI Insight | 2025 | https://conductscience.org/library/papers/41212056 | PubMed |
| 41175420 | A viral vector prime and protein boost vaccine regimen elicits higher binding antibody titers than a homologous viral vector prime-boost regimen. | Immunohorizons | 2025 | https://conductscience.org/library/papers/41175420 | PubMed |
| 41158965 | Advances in the structure-based design of protein vaccines for respiratory infectious diseases. | Comput Struct Biotechnol J | 2025 | https://conductscience.org/library/papers/41158965 | PubMed |
| 41123344 | Development of a cross-protective common cold coronavirus vaccine. | J Virol | 2025 | https://conductscience.org/library/papers/41123344 | PubMed |
| 40387363 | Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding antibodies. | J Virol | 2025 | https://conductscience.org/library/papers/40387363 | PubMed |
| 40295830 | Reduced cross-protective potential of Omicron compared to ancestral SARS-CoV-2 spike vaccines against potentially zoonotic coronaviruses. | Npj Viruses | 2024 | https://conductscience.org/library/papers/40295830 | PubMed |
| 40231823 | ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction. | J Virol | 2025 | https://conductscience.org/library/papers/40231823 | PubMed |
| 39966464 | Aβ42 induces stress granule formation via PACT/PKR pathway. | Sci Rep | 2025 | https://conductscience.org/library/papers/39966464 | PubMed |
| 39852826 | A Spike-Based mRNA Vaccine Encapsulated in Phospholipid 1,2-Dioleoyl-sn-Glycero-3-PhosphoEthanolamine Containing Lipid Nanoparticles Induced Potent B- and T-Cell Responses Associated with Protection Against SARS-CoV-2 Infection and COVID-19-like Symptoms in Hamsters. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/39852826 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34623973
GET https://conductscience.org/api/papers/v1/34623973/references?page=2